SCHEMBL24467452

SCHEMBL24467452

CC(C)C1ON=C(C2CCCN2C(=O)C2CC2)C1C

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 15/20 0.35
▸ HCRTR2 O43614 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18131044 0.68 EPHX2 (0.58) GRM5
SCHEMBL16980491 0.65 PIK3CD (0.44) MAPT
SCHEMBL22893351 0.63 MAPT (0.59) HCRTR2MAPT
SCHEMBL13145213 0.61 GAA (0.44) MAPT
SCHEMBL15723656 0.61 GAA (0.48) MAPT
SCHEMBL21099963 0.60 MAPT (0.41) MAPT
SCHEMBL21696597 0.60 GAA (0.47) HCRTR2MAPT
SCHEMBL27780282 0.59 GRM5 (0.44) GRM5
SCHEMBL13257065 0.59 PIK3CD (0.58) HCRTR2MAPT
SCHEMBL15730093 0.58 GAA (0.64) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4005569-A2 COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO ELA Pharma Ltd (IL) 2022-06-01 — — EP disclosed
Send feedback